CBNDCannabinodiol
A biphenyl of the CBN family, the fully aromatised form of CBD; a trace constituent with no measured pharmacology.
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
C₂₁H₂₆O₂
CAS 39624-81-2
- Family
- PhytocannabinoidMinor
- Origin
- Degradation product
- Molar mass
- 310.40 g/mol
Updated on
In plain terms
Cannabinodiol (CBND) is a rare cannabinoid, isolated in 1977 from hashish. It is chemically close to cannabinol, a molecule that appears when THC degrades. No study has measured its effects.
Receptors and activity
Pharmacology
Cannabinodiol (CBND) was isolated in 1977 from Lebanese hashish by Lousberg et al., who also confirmed its structure by synthesis; Radwan et al. (2021) report that this structure was confirmed by the transformation of cannabinol into cannabinodiol. It is one of only two CBND-type cannabinoids recorded, with its C3 homologue. Its structure is a biphenyl: the fully aromatised form of CBD, and an isomer of cannabinol (C21H26O2) with the pyran ring opened; it lacks the benzo[c]chromene nucleus of the THCs. No enzymatic pathway is known and it is classed among the degradation products of cannabis. No affinity or activity measurement at any biological target was found.
Key sources.
- Lousberg et al. 1977, Phytochemistry 16:595: cannabinodiol, identification and synthesis (new tab)DOI 10.1016/0031-9422(77)80023-X
- Radwan et al. 2021, Molecules: CBND type (new tab)PMID 34066753
- GSRS, UNII CNY5ZTN8E3: cannabinodiol (achiral, CAS 39624-81-2, PubChem 11551346) (new tab)
- ANSM, consolidated list of narcotics, updated 26/06/2026 (new tab)
History
- Source
- Present in cannabis as a degradation product, related to cannabinol (CBN)
Biosynthetic pathway
No known enzymatic pathway. Cannabinodiol was obtained from cannabinol (CBN), a transformation used to confirm its structure in 1977 (Radwan 2021); no source consulted describes its direct formation from CBD in the plant.
Legal framework
- European Union
No EU instrument specific to the molecule. Not named in the schedules of the 1961 and 1971 United Nations conventions, according to annexes I to III of the ANSM consolidated list (26/06/2026). Checked 20/10/2026.
- France
Not a controlled drug: cannabinodiol is not named in the ANSM consolidated list (updated 26/06/2026) and, as a biphenyl molecule without a pyran ring, it does not belong to the generic class of benzo[c]chromene derivatives (ANSM decisions of 22/05/2024 and 03/06/2024). Checked 20/10/2026.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Phytocannabinoid › Minor
- Presence in the plant
Artefact: formed by oxidation, light, heat or solvent
- Chemistry
Type CBND · C5 side chain · neutral form
- Verification
Every fact on this entry was checked against its primary sources on 20 October 2026.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Lousberg et al. 1977, Phytochemistry 16:595: cannabinodiol, identification and synthesis (new tab)DOI 10.1016/0031-9422(77)80023-X
- Radwan et al. 2021, Molecules: CBND type (new tab)PMID 34066753
- GSRS, UNII CNY5ZTN8E3: cannabinodiol (achiral, CAS 39624-81-2, PubChem 11551346) (new tab)
- ANSM, consolidated list of narcotics, updated 26/06/2026 (new tab)
Identifiers
Names
- Common name
- Cannabinodiol
- IUPAC name
- 2-(5-methyl-2-prop-1-en-2-ylphenyl)-5-pentylbenzene-1,3-diol
- Other names
- CBND · CBND-C5 · cannabidinodiol
Identifiers
- Formula
- C₂₁H₂₆O₂
- CAS
- 39624-81-2
- PubChem CID
- 11551346(new tab)
- InChIKey
- TWKHUZXSTKISQC-UHFFFAOYSA-N
- SMILES
- CCCCCC1=
CC(= C(C(= C1) O) C2= C(C= CC(= C2) C) C(= C) C) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.